PubMedThe Lancet. Global health2026-11-14
Community health worker-led hypertension management with independent prescribing in rural Lesotho: a cluster-randomised non-inferiority trial.
Gerber Felix F, Sanchez-Samaniego Giuliana G, Gupta Ravi R, Lejone Thabo Ishmael TI et al.
Hypertension is the leading global risk factor for premature mortality, yet treatment coverage and control remain poor, particularly in low-income and middle-income countries. Whether community health workers can manage hypertension, including independent prescribing and titrating of antihypertensive therapy, remains unknown. We aimed to assess whether hypertension care led by community health workers with independent prescribing was non-inferior to usual facility-based care for maintaining blood pressure control among adults with treated, controlled hypertension.
We conducted a pragmatic, cluster-randomised, open-label, non-inferiority trial in 103 villages in rural Lesotho. Adults with treated, controlled hypertension (<140/90 mm Hg) were eligible. Villages were randomly assigned 1:1, stratified by district and access to health facility, by an independent statistician using a computer-generated sequence to hypertension care led by community health workers, including independent prescribing and titrating of antihypertensive therapy (amlodipine/hydrochlorothiazide combination pills at doses of 5 mg amlodipine and 12·5 mg hydrochlorothiazide or 10 mg amlodipine and 25 mg hydrochlorothiazide) with clinical decision support, or to usual nurse-led, facility-based care. The primary endpoint was blood pressure control at 12 months among all randomised participants except individuals who became pregnant during follow-up, with a non-inferiority margin of -10 percentage points absolute risk difference. The study has been completed and is registered with ClinicalTrials.gov (NCT05684055).
Between Sept 8, 2023, and May 31, 2024, we enrolled 807 participants (417 in 51 control villages, 390 in 50 intervention villages; two empty clusters; mean age 64·4 years [SD 14·3]; 82% female). At 12 months, blood pressure was controlled in 300 (78%) of 386 participants in the intervention group and 303 (74%) of 412 in the control group (adjusted odds ratio 1·29, 95% CI 0·93-1·80); non-inferiority was met. The adjusted absolute risk difference was 5·1% (95% CI -0·9 to 11·2). Serious adverse events (deaths and hospitalisations) were similar in the two groups, with no excess events attributed to the intervention.
These findings support community-based hypertension care with task-sharing to trained community health workers as a promising approach to maintaining blood pressure control, especially in settings with limited access to physician-led and nurse-led hypertension care.
Swiss Agency for Development and Cooperation, World Diabetes Foundation, and Swiss National Science Foundation.